Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Clinical trial NCT00608972 · COMPLETED
Trial details
- NCT number
- NCT00608972
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-16
- Primary completion
- 2015-07-12
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.